The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' (SLNO.O) drug to treat a rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback